The clinical course of Peutz-Jeghers syndrome manifests when germ-line STK11 mutations are accompanied by an acquired defect in the second STK11 allele in somatic cells. The STK11/LKB1 gene functions as a tumor suppressor, which plays an important role in regulating the cell cycle.